The US Department of Commerce has opened the application process for companies to revitalize the domestic semiconductor industrial base. The move is aimed at securing a share of the multi-billion-dollar semiconductor opportunity by 2030 and strengthening leadership in chip manufacturing.

EverGlade Consulting (“EverGlade”), a national consulting firm, announces key promotions and new hires while achieving 20% growth in the first quarter of 2023.

Prepaire Labs, an AI-driven biotechnology company powering drug discovery, repurposing, designing, and development, today announced the appointment of Everglade Consulting, a national consulting firm assisting biotechnology companies to secure non-dilutive federal funding.

EverGlade Consulting has helped a leading biotechnology company land an award from the Biomedical Advanced Research and Development Authority (BARDA) with a potential $1 billion in federal funding.

EverGlade Consulting (“EverGlade”), a national consulting firm, with employees in locations across the country, has launched two new practices to support recent legislation. EverGlade has been on the forefront of U.S. Government (“USG”) efforts to broaden the nation’s domestic industrial base to accommodate the manufacturing of critical supplies and materials.

The Charleston, SC-headquartered firm said the DC office was a “logical next location for a physical presence.” EverGlade has already cut the ribbon on the office and is planning to recruit for roles in regulatory affairs, quality assurance, program management, project management, and government contract administration and compliance.

EverGlade Consulting (“EverGlade”), a national consulting firm, with employees in locations across the country, has opened an office location in Washington, D.C. in the heart of Chinatown. EverGlade’s new office is located at 700 K Street N.W.

CHARLESTON, S.C., Aug. 24, 2022 /PRNewswire/ — EverGlade Consulting (“EverGlade”), a national consulting firm, has successfully partnered with a global leader in mRNA materials used for research, diagnostics, and therapeutics, to successfully manage $39 million in federal funding.

CHARLESTON, S.C., Aug. 19, 2022 /PRNewswire/ — EverGlade Consulting (“EverGlade”), a national consulting firm, has successfully partnered with one of the world’s leading providers of drug delivery technologies to successfully secure and manage $150 million in federal funding. The project will contribute to the global expansion of pharmaceutical lipids in the United States.

EverGlade Consulting (“EverGlade”) formally establishes a team within the company dedicated to supporting U.S. Government (USG) funded Industrial Base Expansion (IBx) programs. This new group will build upon the success EverGlade has experienced in this space over the last few years.